# A Trial to Study BAY1753011 in Patients With Congestive Heart Failure

> **NCT03901729** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 482 (actual)

## Conditions studied

- Heart Failure (HF)

## Interventions

- **DRUG:** BAY 1753011
- **OTHER:** Placebo BAY 1753011
- **DRUG:** Furosemide
- **OTHER:** Placebo Furosemide

## Key facts

- **NCT ID:** NCT03901729
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-29
- **Primary completion:** 2021-04-16
- **Final completion:** 2021-05-21
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2022-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03901729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03901729, "A Trial to Study BAY1753011 in Patients With Congestive Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03901729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*